Quantitative analysis for Nanobiotix S.A. American Depositary Shares (NBTX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (49.0) (grade C). Gem alpha score: 74.0. 32 signals analyzed (27 differentiated alt-data).
NBTX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-07 | $44.46 | $41.80 | $42.61 |
| 2026-05-19 | $46.76 | $44.01 | $46.20 |
| 2026-06-01 | $40.01 | $37.05 | $38.00 |
| 2026-06-11 | $35.33 | $31.71 | $35.33 |
| 2026-06-24 | $35.98 | $33.37 | $34.35 |
| 2026-07-07 | $41.30 | $37.24 | $38.80 |
| 2026-07-17 | $38.38 | $36.12 | $37.79 |
| 2026-07-29 | $38.52 | $36.90 | $37.85 |
| 2026-08-10 | $38.05 | $35.41 | $36.18 |
| 2026-08-20 | $44.72 | $42.74 | $43.68 |
| 2026-09-01 | $41.35 | $38.60 | $39.29 |
| 2026-09-14 | $36.88 | $34.88 | $35.73 |
How Nanobiotix S.A. American Depositary Shares stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
Nanobiotix S.A. American Depositary Shares (NBTX) scores Hold (49.0), and the composite conceals a 74-point disagreement between its dimensions. It is strongest on analyst consensus at 74 and valuation at 73, and weakest on technicals at 39 and AI Alpha (gem) at 0. A stock can carry analyst consensus that high while AI Alpha (gem) sits at 0; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 74 |
| valuation | 73 |
| technicals | 39 |
| AI Alpha (gem) | 0 |
StoQuant analyzes 32 signals (27 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Nanobiotix S.A. American Depositary Shares (NBTX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/NBTX"><img src="https://stoquant.com/badge/NBTX.svg" alt="Nanobiotix S.A. American Depositary Shares (NBTX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.